Annual report
1783.TEDINET S100XC79
Period2024-10-01 → 2025-09-30
Filed2025-12-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 135
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.4bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥8.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥10.6bn | 2022-10-01 → 2023-09-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.0bn | 2021-10-01 → 2022-09-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.9bn | 2020-10-01 → 2021-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥212m | 2024-10-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥702m | 2023-10-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | −¥8m | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥664m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2022-10-01 → 2023-09-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥51m | 2021-10-01 → 2022-09-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥217m | 2020-10-01 → 2021-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥175m | 2024-10-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥743m | 2023-10-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥240m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥291m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2022-10-01 → 2023-09-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥804m | 2021-10-01 → 2022-09-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥977m | 2020-10-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥240m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥291m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥9.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥14.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥7.5bn | at 2023-09-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.5bn | at 2022-09-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥5.3bn | at 2021-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.9bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.6bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.4bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.4bn | at 2023-09-30v | Cons. | Net assets |
| Net assets / equity | ¥5.2bn | at 2022-09-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.4bn | at 2021-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.0bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2023-09-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2022-09-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.1bn | at 2021-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.5bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥4.0bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.0bn | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.3bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.0bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥706m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥230m | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.1bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.6bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥656m | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.1bn | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.7bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-1.41 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.71 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.21 | 2022-10-01 → 2023-09-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.75 | 2021-10-01 → 2022-09-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.48 | 2020-10-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥37.49 | at 2025-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥38.9 | at 2024-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥37.19 | at 2023-09-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥30.64 | at 2022-09-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥50.93 | at 2021-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 69.0% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.8% | at 2023-09-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.9% | at 2022-09-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.5% | at 2021-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 4.5% | 2023-10-01 → 2024-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.4% | 2022-10-01 → 2023-09-30v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 28 | at 2025-09-30 | Cons. | Number of employees |
| Employees | 29 | at 2024-09-30 | Cons. | Number of employees |
| Employees | 21 | at 2023-09-30v | Cons. | Number of employees |
| Employees | 27 | at 2022-09-30v | Cons. | Number of employees |
| Employees | 35 | at 2021-09-30d | Cons. | Number of employees |
| Revenue | ¥616m | 2024-10-01 → 2025-09-30 | Standalone | Net sales |
| Revenue | ¥481m | 2023-10-01 → 2024-09-30 | Standalone | Net sales |
| Revenue | ¥1.0bn | 2022-10-01 → 2023-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥851m | 2021-10-01 → 2022-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.0bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | −¥463m | 2024-10-01 → 2025-09-30 | Standalone | Operating income |
| Operating income | −¥581m | 2023-10-01 → 2024-09-30 | Standalone | Operating income |
| Ordinary income | −¥413m | 2024-10-01 → 2025-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥452m | 2023-10-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥539m | 2022-10-01 → 2023-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2021-10-01 → 2022-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥316m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥579m | 2024-10-01 → 2025-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥362m | 2023-10-01 → 2024-09-30 | Standalone | Income before income taxes |
| Net income | −¥449m | 2024-10-01 → 2025-09-30 | Standalone | Profit loss |
| Net income | −¥127m | 2023-10-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | −¥367m | 2022-10-01 → 2023-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.1bn | 2021-10-01 → 2022-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | −¥418m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥6.7bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥7.4bn | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥7.7bn | at 2023-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.6bn | at 2022-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.2bn | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥115m | at 2025-09-30 | Standalone | Liabilities |
| Total liabilities | ¥429m | at 2024-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥6.6bn | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥7.0bn | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥7.2bn | at 2023-09-30v | Standalone | Net assets |
| Net assets / equity | ¥7.4bn | at 2022-09-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.7bn | at 2021-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥91m | at 2025-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥161m | at 2024-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥-2.64 | 2024-10-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.75 | 2023-10-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.17 | 2022-10-01 → 2023-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.61 | 2021-10-01 → 2022-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.05 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥38.51 | at 2025-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥41.15 | at 2024-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥41.9 | at 2023-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥43.87 | at 2022-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥56.32 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 98.2% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.2% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.1% | at 2023-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 97.5% | at 2022-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.4% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 170,042,851 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 170,042,851 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 170,042,851 | at 2023-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 167,942,851 | at 2022-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 65,992,851 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 14 | at 2025-09-30 | Standalone | Number of employees |
| Employees | 11 | at 2024-09-30 | Standalone | Number of employees |
| Employees | 10 | at 2023-09-30v | Standalone | Number of employees |
| Employees | 11 | at 2022-09-30v | Standalone | Number of employees |
| Employees | 16 | at 2021-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 58
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-10-01 → 2025-09-30 | ¥650,000 |
| Reconciling Itemsreconciling | depreciation | 2024-10-01 → 2025-09-30 | ¥22m |
| Reconciling Itemsreconciling | segment assets | at 2025-09-30 | −¥951m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-09-30 | −¥568m |
| Clean Enagy Businessreportable segment | capex | 2024-10-01 → 2025-09-30 | ¥367m |
| Clean Enagy Businessreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥18m |
| Clean Enagy Businessreportable segment | employees | at 2025-09-30 | 2 pure |
| Clean Enagy Businessreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥236m |
| Clean Enagy Businessreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥236m |
| Clean Enagy Businessreportable segment | segment assets | at 2025-09-30 | ¥942m |
| Clean Enagy Businessreportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥71m |
| Health Carereportable segment | capex | 2024-10-01 → 2025-09-30 | ¥5m |
| Health Carereportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥897,000 |
| Health Carereportable segment | employees | at 2025-09-30 | 2 pure |
| Health Carereportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥138m |
| Health Carereportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥138m |
| Health Carereportable segment | segment assets | at 2025-09-30 | ¥696m |
| Health Carereportable segment | segment profit | 2024-10-01 → 2025-09-30 | −¥1m |
| Real Estatereportable segment | capex | 2024-10-01 → 2025-09-30 | ¥116m |
| Real Estatereportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥9m |
| Real Estatereportable segment | employees | at 2025-09-30 | 17 pure |
| Real Estatereportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥9.0bn |
| Real Estatereportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥9.0bn |
| Real Estatereportable segment | segment assets | at 2025-09-30 | ¥8.5bn |
| Real Estatereportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥710m |
| —segment total | capex | 2024-10-01 → 2025-09-30 | ¥488m |
| —segment total | depreciation | 2024-10-01 → 2025-09-30 | ¥28m |
| —segment total | employees | at 2025-09-30 | 21 pure |
| —segment total | revenue | 2024-10-01 → 2025-09-30 | ¥9.4bn |
| —segment total | revenue external | 2024-10-01 → 2025-09-30 | ¥9.4bn |
| —segment total | segment assets | at 2025-09-30 | ¥10.2bn |
| —segment total | segment profit | 2024-10-01 → 2025-09-30 | ¥780m |
| Reconciling Itemsreconciling | capex | 2023-10-01 → 2024-09-30 | ¥527m |
| Reconciling Itemsreconciling | depreciation | 2023-10-01 → 2024-09-30 | ¥9m |
| Reconciling Itemsreconciling | segment assets | at 2024-09-30 | −¥470m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-09-30 | −¥562m |
| Health Carereportable segment | capex | 2023-10-01 → 2024-09-30 | ¥251,000 |
| Health Carereportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥231,000 |
| Health Carereportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥381m |
| Health Carereportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥381m |
| Health Carereportable segment | segment assets | at 2024-09-30 | ¥667m |
| Health Carereportable segment | segment profit | 2023-10-01 → 2024-09-30 | −¥988,000 |
| Real Estatereportable segment | capex | 2023-10-01 → 2024-09-30 | ¥331m |
| Real Estatereportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥12m |
| Real Estatereportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥8.4bn |
| Real Estatereportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥8.4bn |
| Real Estatereportable segment | segment assets | at 2024-09-30 | ¥14.0bn |
| Real Estatereportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥1.3bn |
| —segment total | capex | 2023-10-01 → 2024-09-30 | ¥331m |
| —segment total | depreciation | 2023-10-01 → 2024-09-30 | ¥12m |
| —segment total | revenue | 2023-10-01 → 2024-09-30 | ¥8.8bn |
| —segment total | revenue external | 2023-10-01 → 2024-09-30 | ¥8.8bn |
| —segment total | segment assets | at 2024-09-30 | ¥14.7bn |
| —segment total | segment profit | 2023-10-01 → 2024-09-30 | ¥1.3bn |
| Clean Enagy Businessreportable segment | employees | at 2025-09-30 | 2 pure |
| Health Carereportable segment | employees | at 2025-09-30 | 1 pure |
| Real Estatereportable segment | employees | at 2025-09-30 | 4 pure |
| —segment total | employees | at 2025-09-30 | 7 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,359
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets per share (5-year summary) | CurrentYearInstant | 37.49 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | -16.48 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | -5.75 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 6.21 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 1.71 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | -1.41 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.635 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.689 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.838 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.465 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.690 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.184 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.045 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | － | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 8.2 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 23.4 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | － | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 4299596000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | -2044362000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 1732794000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -3976454000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 2462605000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | 1058768000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -1422949000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -230349000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -706444000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -1025873000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -3740801000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | 3112427000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -655521000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 4771646000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -2649015000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 2085918000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 1739563000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 2586486000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 2676233000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentYearInstant | 1463949000 | JPY |
| Number of employees | Prior4YearInstant | 35 | |
| Number of employees | Prior3YearInstant | 27 | |
| Number of employees | Prior2YearInstant | 21 | |
| Number of employees | Prior1YearInstant | 29 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |